These stocks can help you boost your passive income. Investors looking for high-yield dividend stocks can find solid options from the Dow Jones Industrial Average (^DJI -0.74%). This index includes 30 industry-leading companies that have the financial fortitude and competitive strengths to put extra cash in your account for decades. The average yield on the S&P 500 (^GSPC -0.37%) and Dow Jones range from 1.13% to 1.50%. These Dow Jones stocks pay yields that are over twice the S&P 500 average and could pay ...

Financial Data and Key Metrics Changes - ResMed achieved a 10% year-over-year reported revenue growth in Q4 FY2025, with a gross margin expansion of 230 basis points year-over-year [6][40]. - Free cash flow for FY2025 was $1.7 billion, providing significant flexibility for investments and shareholder returns [8][48]. - Net income increased by 22%, and non-GAAP diluted earnings per share rose by 23% [47]. Business Line Data and Key Metrics Changes - Device sales globally increased by 8%, while masks and other sales grew by 11% on a constant currency basis [41]. - Residential Care software revenue increased by 9% on a constant currency basis, driven by strong performance in Medifox DAN and HME verticals [42]. Market Data and Key Metrics Changes - Sales in the U.S., Canada, and Latin America increased by 9%, while sales in Europe, Asia, and other regions also rose by 9% on a constant currency basis [40][41]. - Device sales in the U.S., Canada, and Latin America increased by 7%, with masks and other sales up by 12% [41]. Company Strategy and Development Direction - ResMed is focused on building a global digital health ecosystem encompassing sleep health, breathing health, and healthcare delivery in the home [6][7]. - The company aims to achieve its ResMed 2030 goal of improving the lives of over 500 million people [7]. - ResMed is pursuing tuck-in acquisitions to accelerate its growth strategy, with recent acquisitions including Sonderware and Vertuox [9][10]. Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate global macro uncertainties, including tariffs and trade issues [8][36]. - The company is committed to operational excellence and driving ongoing operating leverage, with expectations for gross margin to be in the range of 61% to 63% in FY2026 [43][44]. Other Important Information - ResMed's Board of Directors authorized a 13% increase in the quarterly dividend for FY2026 and plans to significantly increase share repurchase activity [13][50]. - The company is integrating its residential care software business into the broader organization to enhance operational efficiency [29]. Q&A Session Summary Question: Growth in Rest of World Devices - Management noted strong growth in Europe, Asia, and Rest of World Devices at 10%, attributed to various factors including market dynamics and demand generation activities [54][56]. Question: Gross Margin Guidance - Management highlighted that gross margin improvements were driven by procurement efficiencies and favorable foreign currency movements, with expectations for continued improvements [61][64]. Question: Roadmap for Vertuox Post-Acquisition - Management emphasized that Vertuox is part of a broader strategy to enhance home sleep apnea testing capabilities and improve patient flow through the healthcare system [67][75]. Question: U.S. Mask Growth - Management indicated that U.S. mask growth was driven by product innovations and resupply frequency, with expectations for continued strong performance [80][84]. Question: Competitive Bidding and Consolidation - Management discussed the potential impact of competitive bidding on the DME space, emphasizing the importance of advocating for patient access to care [89][96].

Core Viewpoint - Procter & Gamble (P&G) is restructuring its operations due to a slowdown in consumer spending, which includes laying off up to 7,000 workers over the next two years and potentially exiting lower-performing brands [3][4][6] Group 1: Layoffs and Workforce Impact - The layoffs will affect approximately 6.5% of P&G's total workforce, with a disproportionate impact on white-collar jobs, which will see a 15% reduction [5][6] - P&G employs over 30,000 workers in the U.S. and has a global workforce of around 108,000, with 48% of total revenues coming from the U.S. market [4][6] Group 2: Consumer Spending Trends - Consumer spending in the U.S. has slowed, with growth rates dropping from about 4% last year to around 2% this year, and organic sales for North America rising only 1% in the fiscal third quarter [3][4][6] - The CFO noted that consumer consumption has decreased to about 1% in February and March, down from approximately 3% over the past year [6] Group 3: Financial Implications - The restructuring program is estimated to cost between $1 billion and $1.6 billion, aimed at ensuring long-term business viability despite current challenges [6][8] - The company is adjusting its brand portfolio to better align with consumer demand, a strategy it has employed since its founding in 1837 [8]

Group 1: Coca-Cola - Coca-Cola is a 139-year-old brand with annual sales of $47 billion and a year-to-date stock increase of over 14% [2][4] - The company recently raised its quarterly dividend by 5% to $0.51, marking 63 consecutive years of dividend increases, with a forward dividend yield of 2.8% [3][7] - Coca-Cola maintains a payout ratio around 75% of annual earnings, allowing for continued dividend payments even during economic downturns [4][11] - In Q1, Coca-Cola's adjusted revenue grew by 6% year over year, with unit case volume increasing by 2%, indicating stable demand [4][5] - The company sees growth opportunities in emerging markets, which represent about 80% of the global population, with only North America showing a decline in unit case volume [6] Group 2: Procter & Gamble - Procter & Gamble has a strong track record of increasing dividends for 69 consecutive years, supported by a portfolio of leading brands [8] - The company reported $15.5 billion in net income on approximately $84 billion in sales over the last four quarters, demonstrating effective marketing and supply chain efficiency [9] - In fiscal 2025 Q3, P&G's adjusted sales and earnings per share rose by 1% year over year, with management expecting adjusted earnings to increase by 6% to 8% for the fiscal year [10] - P&G increased its quarterly dividend by 5% to $1.0568, resulting in a payout ratio of about two-thirds of annualized earnings, providing flexibility for future increases [11] - Investors purchasing shares at around $160 can expect a forward yield of 2.6%, with the company having paid dividends every year since 1890 [12]

Core Insights - Procter & Gamble (P&G) has a strong reputation for consistent results and dividend growth, having raised its dividend for 69 consecutive years, placing it among the elite "Dividend Kings" [1] - Following the release of its third-quarter fiscal 2025 earnings report, P&G's stock fell by 3.7%, prompting a review of whether this decline is justified or presents a buying opportunity [2] Financial Performance - P&G's second-quarter fiscal 2025 guidance included expectations for full-year sales growth of 2% to 4%, diluted EPS growth of 10% to 12%, core EPS growth of 5% to 7%, $10 billion in dividend payments, and $6 billion to $7 billion in stock buybacks [4] - The latest quarterly results showed a 1% decline in volumes, a 1% increase in price, and a 2% overall decline in net sales, leading to a downward revision in EPS guidance to 6% to 8% for diluted EPS and 2% to 4% for core EPS [5] Consumer Demand and Market Conditions - Consumer demand is under pressure due to various economic factors, including market volatility, job market uncertainty, and rising mortgage rates, leading to decreased retail traffic [7] - P&G's management noted a decline in value consumption in both the U.S. and Europe, with tariffs expected to impact the business by $1 billion to $1.5 billion annually, approximately 3% of the cost of goods sold [8] Competitive Positioning - P&G is better positioned than its competitors to handle tariff pressures due to superior operating margins and a diverse brand portfolio, which helps retain customers even during spending pullbacks [10] - The company continues to innovate with new products across its brands, such as the launch of OxyBoost Power Pods and Gain Odor Defense, allowing it to maintain customer loyalty [11][12] Dividend and Capital Return - Despite the challenges, P&G's dividend remains secure, with a yield of 2.6% and plans to return $6 billion to $7 billion to shareholders in fiscal 2025, reflecting the strength of its capital return program [14] - The stock is currently trading just 3.3% above its 52-week low, resulting in a price-to-earnings (P/E) ratio of 25.6, which is close to its 10-year median P/E of 25.7, presenting a potentially better value for investors [15] Long-term Outlook - While P&G's stock may face near-term pressure due to tariff uncertainties, the long-term investment thesis remains intact, making it a solid option for risk-averse investors seeking reliable passive income [16][17]